341 related articles for article (PubMed ID: 12847210)
1. Cutting edge: granzymes A and B are not essential for perforin-mediated tumor rejection.
Smyth MJ; Street SE; Trapani JA
J Immunol; 2003 Jul; 171(2):515-8. PubMed ID: 12847210
[TBL] [Abstract][Full Text] [Related]
2. Granzyme A and B-deficient killer lymphocytes are defective in eliciting DNA fragmentation but retain potent in vivo anti-tumor capacity.
Davis JE; Smyth MJ; Trapani JA
Eur J Immunol; 2001 Jan; 31(1):39-47. PubMed ID: 11169436
[TBL] [Abstract][Full Text] [Related]
3. In vitro- and ex vivo-derived cytolytic leukocytes from granzyme A x B double knockout mice are defective in granule-mediated apoptosis but not lysis of target cells.
Simon MM; Hausmann M; Tran T; Ebnet K; Tschopp J; ThaHla R; Müllbacher A
J Exp Med; 1997 Nov; 186(10):1781-6. PubMed ID: 9362539
[TBL] [Abstract][Full Text] [Related]
4. Distinct requirements for IFNs and STAT1 in NK cell function.
Lee CK; Rao DT; Gertner R; Gimeno R; Frey AB; Levy DE
J Immunol; 2000 Oct; 165(7):3571-7. PubMed ID: 11034357
[TBL] [Abstract][Full Text] [Related]
5. A clathrin/dynamin- and mannose-6-phosphate receptor-independent pathway for granzyme B-induced cell death.
Trapani JA; Sutton VR; Thia KY; Li YQ; Froelich CJ; Jans DA; Sandrin MS; Browne KA
J Cell Biol; 2003 Jan; 160(2):223-33. PubMed ID: 12538642
[TBL] [Abstract][Full Text] [Related]
6. Killing by cytotoxic T cells and natural killer cells: multiple granule serine proteases as initiators of DNA fragmentation.
Trapani JA; Smyth MJ
Immunol Cell Biol; 1993 Jun; 71 ( Pt 3)():201-8. PubMed ID: 8349302
[TBL] [Abstract][Full Text] [Related]
7. Granzyme B and the downstream granzymes C and/or F are important for cytotoxic lymphocyte functions.
Revell PA; Grossman WJ; Thomas DA; Cao X; Behl R; Ratner JA; Lu ZH; Ley TJ
J Immunol; 2005 Feb; 174(4):2124-31. PubMed ID: 15699143
[TBL] [Abstract][Full Text] [Related]
8. Granzymes are essential for natural killer cell-mediated and perf-facilitated tumor control.
Pardo J; Balkow S; Anel A; Simon MM
Eur J Immunol; 2002 Oct; 32(10):2881-7. PubMed ID: 12355441
[TBL] [Abstract][Full Text] [Related]
9. Cutting edge: tumor rejection mediated by NKG2D receptor-ligand interaction is dependent upon perforin.
Hayakawa Y; Kelly JM; Westwood JA; Darcy PK; Diefenbach A; Raulet D; Smyth MJ
J Immunol; 2002 Nov; 169(10):5377-81. PubMed ID: 12421908
[TBL] [Abstract][Full Text] [Related]
10. Independent roles of perforin, granzymes, and Fas in the control of Friend retrovirus infection.
Zelinskyy G; Balkow S; Schimmer S; Schepers K; Simon MM; Dittmer U
Virology; 2004 Dec; 330(2):365-74. PubMed ID: 15567431
[TBL] [Abstract][Full Text] [Related]
11. Induction of natural killer cell activity and perforin and granzyme B gene expression following continuous culture of short pulse with interleukin-12 in young and old mice.
Argentati K; Bartozzi B; Bernardini G; Di Stasio G; Provinciali M
Eur Cytokine Netw; 2000 Mar; 11(1):59-66. PubMed ID: 10705300
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of CTL induction by rapamycin: IL-2 rescues granzyme B and perforin expression but only partially restores cytotoxic activity.
Makrigiannis AP; Hoskin DW
J Immunol; 1997 Nov; 159(10):4700-7. PubMed ID: 9366393
[TBL] [Abstract][Full Text] [Related]
13. Perforin- and Fas-dependent mechanisms of natural killer cell-mediated rejection of incompatible bone marrow cell grafts.
Taylor MA; Ward B; Schatzle JD; Bennett M
Eur J Immunol; 2002 Mar; 32(3):793-9. PubMed ID: 11870623
[TBL] [Abstract][Full Text] [Related]
14. Functional defects of NK cells treated with chloroquine mimic the lytic defects observed in perforin-deficient mice.
Austin Taylor M; Bennett M; Kumar V; Schatzle JD
J Immunol; 2000 Nov; 165(9):5048-53. PubMed ID: 11046034
[TBL] [Abstract][Full Text] [Related]
15. Target cell apoptosis induced by cytotoxic T cells and natural killer cells involves synergy between the pore-forming protein, perforin, and the serine protease, granzyme B.
Trapani JA
Aust N Z J Med; 1995 Dec; 25(6):793-9. PubMed ID: 8770355
[TBL] [Abstract][Full Text] [Related]
16. Tumor immunity in perforin-deficient mice: a role for CD95 (Fas/APO-1).
Rosen D; Li JH; Keidar S; Markon I; Orda R; Berke G
J Immunol; 2000 Mar; 164(6):3229-35. PubMed ID: 10706715
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of lymphocyte-mediated cytolysis: functional cytolytic T cells lacking perforin and granzymes.
Berke G; Rosen D; Ronen D
Immunology; 1993 Jan; 78(1):105-12. PubMed ID: 8436395
[TBL] [Abstract][Full Text] [Related]
18. Tumor-specific CTL kill murine renal cancer cells using both perforin and Fas ligand-mediated lysis in vitro, but cause tumor regression in vivo in the absence of perforin.
Seki N; Brooks AD; Carter CR; Back TC; Parsoneault EM; Smyth MJ; Wiltrout RH; Sayers TJ
J Immunol; 2002 Apr; 168(7):3484-92. PubMed ID: 11907109
[TBL] [Abstract][Full Text] [Related]
19. Stably transfected antisense granzyme B and perforin constructs inhibit human granule-mediated lytic ability.
Bochan MR; Goebel WS; Brahmi Z
Cell Immunol; 1995 Sep; 164(2):234-9. PubMed ID: 7656332
[TBL] [Abstract][Full Text] [Related]
20. Apoptotic pathways are selectively activated by granzyme A and/or granzyme B in CTL-mediated target cell lysis.
Pardo J; Bosque A; Brehm R; Wallich R; Naval J; Müllbacher A; Anel A; Simon MM
J Cell Biol; 2004 Nov; 167(3):457-68. PubMed ID: 15534000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]